Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4789420
Max Phase: Preclinical
Molecular Formula: C53H74N12O10S
Molecular Weight: 1071.32
Molecule Type: Unknown
Associated Items:
ID: ALA4789420
Max Phase: Preclinical
Molecular Formula: C53H74N12O10S
Molecular Weight: 1071.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(N)=O
Standard InChI: InChI=1S/C53H74N12O10S/c1-29(2)44(46(57)68)64-52(74)42(28-76)63-50(72)39(25-32-17-19-34(66)20-18-32)60-48(70)38(16-10-11-23-54)59-51(73)41(26-33-27-58-37-15-9-8-14-35(33)37)61-49(71)40(24-31-12-6-5-7-13-31)62-53(75)45(30(3)4)65-47(69)36(55)21-22-43(56)67/h5-9,12-15,17-20,27,29-30,36,38-42,44-45,58,66,76H,10-11,16,21-26,28,54-55H2,1-4H3,(H2,56,67)(H2,57,68)(H,59,73)(H,60,70)(H,61,71)(H,62,75)(H,63,72)(H,64,74)(H,65,69)/t36-,38-,39-,40-,41-,42-,44-,45-/m0/s1
Standard InChI Key: NMHJNYCPSPDKEK-LBKVYCCMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1071.32 | Molecular Weight (Monoisotopic): 1070.5372 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):